A. S. Chernyavskaya, O. I. Simonova, N. Yu. Kashirskaya
Introduction. Post COVID-19 condition in children causes variety of persistent symptoms such as fatigue, post-exertional malaise, cognitive problems, muscle pain and can affect different aspects of patient’s life. Aim. The aim of this study was to describe the prevalence and characteristics of persistent symptoms of COVID-19 in non-hospitalized pediatric patients one year after infection. Material and methods. This is a single center case-control study including children and young people (COVID-19 as cases and other acute respiratory infections as controls). A survey using ISARIC Global COVID-19 paediatric follow-up questionnaire was conducted by a pediatrician in person or via telephone interview one year after infection. Post COVID-19 condition was defined using WHO case definition. Results and discussion. 206 cases and 176 controls were analyzed. The mean ages of cases and controls were 8.8 years and 8.4 years accordingly, with 55% and 50% being females. The most frequent persistent symptoms in cases at 1 year were loss of taste – 8.7% [5.3%; 13.1%], fatigue – 8.7% [4.9%; 13.1%], chest pain – 4.9% [1.9%; 7.8%], headache – 2.4% [1.0%; 4.9%], tingling – 2.4% [0.5%; 4.9%]. Controls had similar persistent symptoms, but cases had significantly higher rates of sensory disturbances (taste/smell alterations) and fatigue. There were no statistically significant differences between other groups of symptoms found. Prevalence of post COVID-19 condition in cases group was 1.5% [0.0%; 3.4%]. Conclusion. Prevalence of post COVID-19 condition in children one year after mild infection is low. However, compared to other respiratory infections, COVID-19 may cause persistent taste/smell disturbances and fatigue.
{"title":"Characteristics of post COVID-19 condition in children after mild COVID-19","authors":"A. S. Chernyavskaya, O. I. Simonova, N. Yu. Kashirskaya","doi":"10.21518/ms2023-386","DOIUrl":"https://doi.org/10.21518/ms2023-386","url":null,"abstract":"Introduction. Post COVID-19 condition in children causes variety of persistent symptoms such as fatigue, post-exertional malaise, cognitive problems, muscle pain and can affect different aspects of patient’s life. Aim. The aim of this study was to describe the prevalence and characteristics of persistent symptoms of COVID-19 in non-hospitalized pediatric patients one year after infection. Material and methods. This is a single center case-control study including children and young people (COVID-19 as cases and other acute respiratory infections as controls). A survey using ISARIC Global COVID-19 paediatric follow-up questionnaire was conducted by a pediatrician in person or via telephone interview one year after infection. Post COVID-19 condition was defined using WHO case definition. Results and discussion. 206 cases and 176 controls were analyzed. The mean ages of cases and controls were 8.8 years and 8.4 years accordingly, with 55% and 50% being females. The most frequent persistent symptoms in cases at 1 year were loss of taste – 8.7% [5.3%; 13.1%], fatigue – 8.7% [4.9%; 13.1%], chest pain – 4.9% [1.9%; 7.8%], headache – 2.4% [1.0%; 4.9%], tingling – 2.4% [0.5%; 4.9%]. Controls had similar persistent symptoms, but cases had significantly higher rates of sensory disturbances (taste/smell alterations) and fatigue. There were no statistically significant differences between other groups of symptoms found. Prevalence of post COVID-19 condition in cases group was 1.5% [0.0%; 3.4%]. Conclusion. Prevalence of post COVID-19 condition in children one year after mild infection is low. However, compared to other respiratory infections, COVID-19 may cause persistent taste/smell disturbances and fatigue.","PeriodicalId":36137,"journal":{"name":"Meditsinskiy Sovet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135509587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
T. G. Malanicheva, N. V. Ziatdinova, G. G. Gataullina, L. M. Mukhametzanova
According to WHO, pneumococcal infection (PI) is considered one of the most dangerous of all vaccine-preventable diseases and, before vaccination, led to the death of up to 1.6 million people per year, of which from 0.7 to 1 million were children. In the prevention of PI, specific prevention occupies a special place. For the first time in 2014, vaccination against PI with pneumococcal conjugate vaccine was included in the national calendar of preventive vaccinations. International practice of using pneumococcal vaccine has shown that timely vaccination can produce positive results in the fight against PI. Under observation were 55 children who were vaccinated against PI with the pneumococcal polysaccharide conjugate vaccine (adsorbed), 13 valent according to the national calendar of preventive vaccinations of the Russian Federation. It was revealed that post-vaccination complications after vaccination did not occur in any child. General post-vaccination reactions were observed in the form of a short-term increase in temperature, loss of appetite and sleep disturbances, as well as local reactions in the form of edema, hyperemia, and hardening at the site of vaccine administration. We studied the incidence of community-acquired pneumonia (CAP), acute otitis media and acute respiratory infections among 55 children of the first year of life vaccinated at 2 months and 4.5 months (main group) and 50 children for various reasons not vaccinated against PI (comparison group). A study of the long-term results of 2-fold vaccination in the first year of life and revaccination at 15 months against PV based on observation of children for two years showed that children of the main group, compared with the comparison group, were 3.3 times less likely to suffer from PV, 2.7 times acute otitis and 1.7 times acute respiratory infections, p < 0.05. The data obtained show the high efficiency and safety of vaccinating children against PI with the pneumococcal vaccine.
{"title":"Evaluating clinical effectiveness and safety of pneumococcal immunization of infants","authors":"T. G. Malanicheva, N. V. Ziatdinova, G. G. Gataullina, L. M. Mukhametzanova","doi":"10.21518/ms2023-361","DOIUrl":"https://doi.org/10.21518/ms2023-361","url":null,"abstract":"According to WHO, pneumococcal infection (PI) is considered one of the most dangerous of all vaccine-preventable diseases and, before vaccination, led to the death of up to 1.6 million people per year, of which from 0.7 to 1 million were children. In the prevention of PI, specific prevention occupies a special place. For the first time in 2014, vaccination against PI with pneumococcal conjugate vaccine was included in the national calendar of preventive vaccinations. International practice of using pneumococcal vaccine has shown that timely vaccination can produce positive results in the fight against PI. Under observation were 55 children who were vaccinated against PI with the pneumococcal polysaccharide conjugate vaccine (adsorbed), 13 valent according to the national calendar of preventive vaccinations of the Russian Federation. It was revealed that post-vaccination complications after vaccination did not occur in any child. General post-vaccination reactions were observed in the form of a short-term increase in temperature, loss of appetite and sleep disturbances, as well as local reactions in the form of edema, hyperemia, and hardening at the site of vaccine administration. We studied the incidence of community-acquired pneumonia (CAP), acute otitis media and acute respiratory infections among 55 children of the first year of life vaccinated at 2 months and 4.5 months (main group) and 50 children for various reasons not vaccinated against PI (comparison group). A study of the long-term results of 2-fold vaccination in the first year of life and revaccination at 15 months against PV based on observation of children for two years showed that children of the main group, compared with the comparison group, were 3.3 times less likely to suffer from PV, 2.7 times acute otitis and 1.7 times acute respiratory infections, p < 0.05. The data obtained show the high efficiency and safety of vaccinating children against PI with the pneumococcal vaccine.","PeriodicalId":36137,"journal":{"name":"Meditsinskiy Sovet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135509584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
N. K. Shumeyko, O. V. Zaytseva, N. B. Serebrovskaya, I. P. Ostroukhova, A. N. Antonenko, O. Yu. Krasnikova
The article is devoted to one of the urgent problems of pediatric gastroenterology – inflammatory bowel diseases (IBD), which currently include ulcerative colitis (UC) and Crohn’s disease (CD). The prevalence of IBD is inferior to other gastroenterological diseases, but according to the severity of the course, the frequency of complications and the level of mortality, IBD occupy one of the leading places in the structure of diseases of the gastrointestinal tract. The problem of IBD constantly attracts the attention of doctors of various specialties – pediatricians, gastroenterologists, surgeons and others. This is due to an increase in the incidence of this pathology, a variety of clinical manifestations, including extra-intestinal manifestations, faced by doctors of various specialties. In childhood, there is more often a greater prevalence of the lesion, a less specific and erased picture, there is an impact on the physical development of the child. The article provides information on the prevalence, significant factors in the development of the disease; research data revealing the relationship between taking med ications and the risk of IBD onset. The problems of the pathogenesis of the disease, the significance of the genetic status in the development of CD and UC are described. The article presents data on the features of the clinical picture of UC in childhood, recommendations for the primary diagnosis of IBD, including modern laboratory and instrumental research methods. The article also describes the recommended international criteria for assessing the severity of IBD and the problems of differential diagnosis. As a demonstration, the authors’ own observations are presented. The clinical example describes an atypical case of UC in a teenager, occurring with the involvement of the cardiovascular, bronchopulmonary and urinary systems with the development of polyserositis. Early diagnosis of IBD is necessary to prevent disability of patients, ensure further development of the child, improve the quality of life.
{"title":"Pediatric inflammatory bowel diseases, features of the disease course: a clinical case of complicated course of ulcerative colitis","authors":"N. K. Shumeyko, O. V. Zaytseva, N. B. Serebrovskaya, I. P. Ostroukhova, A. N. Antonenko, O. Yu. Krasnikova","doi":"10.21518/ms2023-363","DOIUrl":"https://doi.org/10.21518/ms2023-363","url":null,"abstract":"The article is devoted to one of the urgent problems of pediatric gastroenterology – inflammatory bowel diseases (IBD), which currently include ulcerative colitis (UC) and Crohn’s disease (CD). The prevalence of IBD is inferior to other gastroenterological diseases, but according to the severity of the course, the frequency of complications and the level of mortality, IBD occupy one of the leading places in the structure of diseases of the gastrointestinal tract. The problem of IBD constantly attracts the attention of doctors of various specialties – pediatricians, gastroenterologists, surgeons and others. This is due to an increase in the incidence of this pathology, a variety of clinical manifestations, including extra-intestinal manifestations, faced by doctors of various specialties. In childhood, there is more often a greater prevalence of the lesion, a less specific and erased picture, there is an impact on the physical development of the child. The article provides information on the prevalence, significant factors in the development of the disease; research data revealing the relationship between taking med ications and the risk of IBD onset. The problems of the pathogenesis of the disease, the significance of the genetic status in the development of CD and UC are described. The article presents data on the features of the clinical picture of UC in childhood, recommendations for the primary diagnosis of IBD, including modern laboratory and instrumental research methods. The article also describes the recommended international criteria for assessing the severity of IBD and the problems of differential diagnosis. As a demonstration, the authors’ own observations are presented. The clinical example describes an atypical case of UC in a teenager, occurring with the involvement of the cardiovascular, bronchopulmonary and urinary systems with the development of polyserositis. Early diagnosis of IBD is necessary to prevent disability of patients, ensure further development of the child, improve the quality of life.","PeriodicalId":36137,"journal":{"name":"Meditsinskiy Sovet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135509591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Type 1 diabetes is a highly prevalent disorder worldwide and the commonest form of diabetes in children and adolescents. The incidence rates are steadily increasing, despite numerous efforts aimed at finding the possibility to detect and interrupt autoimmune inflammation in the pancreas at preclinical stages. Modern technologies make it possible to set metabolic control goals that are increasingly closer to physiological ones. The article presents recommendations regarding new technologies for glycaemic control and criteria for compensation of T1DM in children and adolescents in accordance with the updated guidelines of the International Society of Diabetes Mellitus in Children and Adolescents (ISPAD, 2022) and the Russian standards for self-monitoring of glycemia using an individual blood glucose meter associated with the use of continuous glucose monitoring technologies to assess the accuracy and/or calibration of monitoring data and address treatment adjustment issues. The possibilities and advantages of modern blood glucose meters are highlighted both in terms of accuracy of readings and functional expandability. Clinical cases demonstrating the importance of using blood glucose meters in decision-making by patients (adolescents) with type 1 diabetes who receive insulin pump therapy are presented. Excessive haste in decision-making by patients resulting in non-target results on glycaemic levels, which could have been avoided with timely measurement of blood glucose levels with a glucose meter was stressed. The great role of continuous education of children and adolescents with T1DM together with assessment and analysis of the significance of new and existing technologies for diagnosis, treatment, and monitoring of this chronic disease is emphasized, so that the patients and their parents can fully and effectively use constantly emerging opportunities.
{"title":"Current opportunities for glycaemic control in children and adolescents with type 1 diabetes mellitus: the path to achieving a goal","authors":"I. L. Nikitina, A. O. Plaksina","doi":"10.21518/ms2023-357","DOIUrl":"https://doi.org/10.21518/ms2023-357","url":null,"abstract":"Type 1 diabetes is a highly prevalent disorder worldwide and the commonest form of diabetes in children and adolescents. The incidence rates are steadily increasing, despite numerous efforts aimed at finding the possibility to detect and interrupt autoimmune inflammation in the pancreas at preclinical stages. Modern technologies make it possible to set metabolic control goals that are increasingly closer to physiological ones. The article presents recommendations regarding new technologies for glycaemic control and criteria for compensation of T1DM in children and adolescents in accordance with the updated guidelines of the International Society of Diabetes Mellitus in Children and Adolescents (ISPAD, 2022) and the Russian standards for self-monitoring of glycemia using an individual blood glucose meter associated with the use of continuous glucose monitoring technologies to assess the accuracy and/or calibration of monitoring data and address treatment adjustment issues. The possibilities and advantages of modern blood glucose meters are highlighted both in terms of accuracy of readings and functional expandability. Clinical cases demonstrating the importance of using blood glucose meters in decision-making by patients (adolescents) with type 1 diabetes who receive insulin pump therapy are presented. Excessive haste in decision-making by patients resulting in non-target results on glycaemic levels, which could have been avoided with timely measurement of blood glucose levels with a glucose meter was stressed. The great role of continuous education of children and adolescents with T1DM together with assessment and analysis of the significance of new and existing technologies for diagnosis, treatment, and monitoring of this chronic disease is emphasized, so that the patients and their parents can fully and effectively use constantly emerging opportunities.","PeriodicalId":36137,"journal":{"name":"Meditsinskiy Sovet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135978214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
O. V. Borisova, N. M. Bochkareva, N. S. Polezhaeva, O. N. Yashkina, N. G. Tsareva, D. M. Gadelshina
Introduction. Taking into account the changeable viral landscape of pathogens, the persistence of seasonal morbidity at a high level, and the refusal of a number of parents to be vaccinated against influenza, the interest of scientists and practitioners in the use of endogenous interferon inducers is increasing. Studies by domestic authors have proven that Kagocel® is highly effective in the prevention and treatment of influenza and other ARIs. Aim. Evaluation of the efficacy and safety of Kagocel® for the prevention of influenza and ARIs in children aged 3–18 years old on an outpatient basis during the epidemic rise of respiratory viral infections in 2022–2023. Materials and methods. A prospective comparative analysis of cases of prevention of influenza and ARIs by Kagocel® in children was carried out: group 1 – main (n = 32). Kagocel® was prescribed according to the scheme for a month. The comparison group consisted of patients vaccinated against influenza, who did not receive drugs for the prevention of acute respiratory viral infections: group 2 – comparison (n = 28). Results and discussion. The index of preventive efficacy of Kagocel® was 3.0, the efficiency ratio was quite high – 66.7%. The elimination of the main clinical symptoms of the disease was noted on average by the 2nd–3rd day of illness. Prophylactic administration of the drug allowed to reduce the incidence of influenza and ARIs by 3 times; reduce the number of complications from these diseases by 4 times. The economic feasibility of prophylaxis with Kagocel® has been proven, direct costs for the treatment of one patient have decreased by 3.6 times. The interferon inducer was well tolerated, no side effects of the drug were detected. Conclusion. Endogenous interferon inducer Kagocel® can be used for prophylactic purposes during the seasonal rise in the incidence of influenza and ARIs.
{"title":"Experience of using an interferon inducer in the prevention of influenza and acute respiratory viral infections in children","authors":"O. V. Borisova, N. M. Bochkareva, N. S. Polezhaeva, O. N. Yashkina, N. G. Tsareva, D. M. Gadelshina","doi":"10.21518/ms2023-315","DOIUrl":"https://doi.org/10.21518/ms2023-315","url":null,"abstract":"Introduction. Taking into account the changeable viral landscape of pathogens, the persistence of seasonal morbidity at a high level, and the refusal of a number of parents to be vaccinated against influenza, the interest of scientists and practitioners in the use of endogenous interferon inducers is increasing. Studies by domestic authors have proven that Kagocel® is highly effective in the prevention and treatment of influenza and other ARIs. Aim. Evaluation of the efficacy and safety of Kagocel® for the prevention of influenza and ARIs in children aged 3–18 years old on an outpatient basis during the epidemic rise of respiratory viral infections in 2022–2023. Materials and methods. A prospective comparative analysis of cases of prevention of influenza and ARIs by Kagocel® in children was carried out: group 1 – main (n = 32). Kagocel® was prescribed according to the scheme for a month. The comparison group consisted of patients vaccinated against influenza, who did not receive drugs for the prevention of acute respiratory viral infections: group 2 – comparison (n = 28). Results and discussion. The index of preventive efficacy of Kagocel® was 3.0, the efficiency ratio was quite high – 66.7%. The elimination of the main clinical symptoms of the disease was noted on average by the 2nd–3rd day of illness. Prophylactic administration of the drug allowed to reduce the incidence of influenza and ARIs by 3 times; reduce the number of complications from these diseases by 4 times. The economic feasibility of prophylaxis with Kagocel® has been proven, direct costs for the treatment of one patient have decreased by 3.6 times. The interferon inducer was well tolerated, no side effects of the drug were detected. Conclusion. Endogenous interferon inducer Kagocel® can be used for prophylactic purposes during the seasonal rise in the incidence of influenza and ARIs.","PeriodicalId":36137,"journal":{"name":"Meditsinskiy Sovet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135978392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction. The nutrition of young children determines the vector of the physical and neuro-psychological development of the child, forms the characteristics of eating behavior. Aim. To study the features of the nutritional practice of young children living in Belgorod, and to evaluate the success of the implementation of the Program for optimizing the nutrition of children aged 1 to 3 years in the Russian Federation in pediatric practice. Materials and methods. We interviewed 307 women with young children born at 38–41 weeks of gestation with an Apgar score of at least 8 points. In addition, we developed a questionnaire that allows retrospectively assessing the regime and diet of young children. Results. We identified the following problems of young children nutrition: non-compliance with the diet – only 18.1% of the respondents strictly adhered to the regime, the use of confectionery and sweets as snack products in almost a third of children (27%) which were introduced into the diet in 44% of children aged 1–2 years, and in 43% of children after 2 years. According to the survey data, 38.2% of respondents used industrial food products for young children in the form of milk-based drinks, but the duration of their use was limited to the second year of life. 14% of children used other industrial food products for young children. Discussion. The presented dietary habits of children lead to the formation of incorrect eating habits, aggravating the imbalance of the diet, increasing the risk of health problems. Conclusion. The results of the study show the need for further work on the active implementation of the existing recommendations for optimizing the nutrition of young children. The FrutoNyanya brand includes a wide selection of industrially produced baby food products, allowing you to achieve a wide variety, but also healthy food products.
{"title":"Actual nutrition of young children: how to make what you want real","authors":"M. M. Gurova, E. A. Protsenko","doi":"10.21518/ms2023-316","DOIUrl":"https://doi.org/10.21518/ms2023-316","url":null,"abstract":"Introduction. The nutrition of young children determines the vector of the physical and neuro-psychological development of the child, forms the characteristics of eating behavior. Aim. To study the features of the nutritional practice of young children living in Belgorod, and to evaluate the success of the implementation of the Program for optimizing the nutrition of children aged 1 to 3 years in the Russian Federation in pediatric practice. Materials and methods. We interviewed 307 women with young children born at 38–41 weeks of gestation with an Apgar score of at least 8 points. In addition, we developed a questionnaire that allows retrospectively assessing the regime and diet of young children. Results. We identified the following problems of young children nutrition: non-compliance with the diet – only 18.1% of the respondents strictly adhered to the regime, the use of confectionery and sweets as snack products in almost a third of children (27%) which were introduced into the diet in 44% of children aged 1–2 years, and in 43% of children after 2 years. According to the survey data, 38.2% of respondents used industrial food products for young children in the form of milk-based drinks, but the duration of their use was limited to the second year of life. 14% of children used other industrial food products for young children. Discussion. The presented dietary habits of children lead to the formation of incorrect eating habits, aggravating the imbalance of the diet, increasing the risk of health problems. Conclusion. The results of the study show the need for further work on the active implementation of the existing recommendations for optimizing the nutrition of young children. The FrutoNyanya brand includes a wide selection of industrially produced baby food products, allowing you to achieve a wide variety, but also healthy food products.","PeriodicalId":36137,"journal":{"name":"Meditsinskiy Sovet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135978395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. V. Dmitriev, R. A. Gudkov, V. I. Petrova, N. V. Fedina, A. L. Zaplatnikov
According to the World Health Organization report, in 2019 47 million children under 5 were wasted, of which 14.3 million were severely wasted. In most cases, the main reason for nutritional deficiencies in the world is a child’s diet low in calories, dietary protein deficiency and inferiority, as well as inadequate intake of vitamins and minerals. The article presents a modern literature review devoted to the main problems in creating adapted formulas for infants who are deprived of the opportunity of getting breastfeeding. Among the most pressing problems are: difficulties in bringing the total protein concentration in the formula to the breast milk level while keeping an adequate amino acid profile, the high risk of animal milk protein allergies in infants, unfulfilled hopes for the preventive effect of partially hydrolysed formulas in relation to the development of allergic diseases, as well as the high prevalence of functional gastrointestinal diseases in children who are formula-fed. At the same time, it was emphasized that the use of goat’s milk as a protein base for basic infant formulas may in the future help solve some of the above problems. The protein component of goat’s milk compares favourably with cow’s milk, and the amino acid composition helps reduce protein concentration in the finished formula enriched with whey fraction to the recommended level. The article stresses that there is a need to continue studies on the effectiveness and safety of adapted goat’s milk formulas in infants to give definite answers to the questions posed.
{"title":"Modern adapted infant formulas: problem status and prospects for solving","authors":"A. V. Dmitriev, R. A. Gudkov, V. I. Petrova, N. V. Fedina, A. L. Zaplatnikov","doi":"10.21518/ms2023-336","DOIUrl":"https://doi.org/10.21518/ms2023-336","url":null,"abstract":"According to the World Health Organization report, in 2019 47 million children under 5 were wasted, of which 14.3 million were severely wasted. In most cases, the main reason for nutritional deficiencies in the world is a child’s diet low in calories, dietary protein deficiency and inferiority, as well as inadequate intake of vitamins and minerals. The article presents a modern literature review devoted to the main problems in creating adapted formulas for infants who are deprived of the opportunity of getting breastfeeding. Among the most pressing problems are: difficulties in bringing the total protein concentration in the formula to the breast milk level while keeping an adequate amino acid profile, the high risk of animal milk protein allergies in infants, unfulfilled hopes for the preventive effect of partially hydrolysed formulas in relation to the development of allergic diseases, as well as the high prevalence of functional gastrointestinal diseases in children who are formula-fed. At the same time, it was emphasized that the use of goat’s milk as a protein base for basic infant formulas may in the future help solve some of the above problems. The protein component of goat’s milk compares favourably with cow’s milk, and the amino acid composition helps reduce protein concentration in the finished formula enriched with whey fraction to the recommended level. The article stresses that there is a need to continue studies on the effectiveness and safety of adapted goat’s milk formulas in infants to give definite answers to the questions posed.","PeriodicalId":36137,"journal":{"name":"Meditsinskiy Sovet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135978215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
I. M. Kirichenko, V. I. Popadyuk, N. S. Kozlova, A. I. Chernolev
Sore throat is the most common reason for visiting primary care doctors, pediatricians, and ENT doctors. Acute sore throat, as a rule, is not an independent disease and most often accompanies tonsillopharyngitis caused by respiratory viral infections. In childhood, the share of acute respiratory viral infections among other infectious diseases can reach up to 90%, and the proportion of frequently ill children ranges from 30 to 50%. A feature of frequently ill children is a high incidence of illness, regardless of seasonality, and a tendency to a protracted course of the inflammatory process. Uncontrolled systemic antibiotic therapy for acute sore throat in frequently ill children leads to the development of dysbacteriosis and a decrease in mucosal immunity. The use of the topical antibacterial drug Faringazon for sore throat in children reduces inflammation in both viral and bacterial infections and reduces the need for systemic antibiotic therapy. The active substance of Ambazon has a bacteriostatic effect when is kept in the mouth until it resorbs and is effective against Streptococcus haemolyticus , Streptococcus pneumoniae , Streptococcus viridans , and also has antifungal effects against Candida albicans yeast fungus, which is a saprophyte, but exhibits pathogenic properties in decreased body’s immune defence and dysbiosis. The use of topical antimicrobial therapy helps reduce inflammation and speed up the recovery of patients without prescription of systemic antibiotics, and also ensures the preservation of microbiome, reducing the probability of emergence of antibiotic resistant strains to the minimum.
{"title":"Acute sore throat in frequently ill children: potential of topical therapy","authors":"I. M. Kirichenko, V. I. Popadyuk, N. S. Kozlova, A. I. Chernolev","doi":"10.21518/ms2023-337","DOIUrl":"https://doi.org/10.21518/ms2023-337","url":null,"abstract":"Sore throat is the most common reason for visiting primary care doctors, pediatricians, and ENT doctors. Acute sore throat, as a rule, is not an independent disease and most often accompanies tonsillopharyngitis caused by respiratory viral infections. In childhood, the share of acute respiratory viral infections among other infectious diseases can reach up to 90%, and the proportion of frequently ill children ranges from 30 to 50%. A feature of frequently ill children is a high incidence of illness, regardless of seasonality, and a tendency to a protracted course of the inflammatory process. Uncontrolled systemic antibiotic therapy for acute sore throat in frequently ill children leads to the development of dysbacteriosis and a decrease in mucosal immunity. The use of the topical antibacterial drug Faringazon for sore throat in children reduces inflammation in both viral and bacterial infections and reduces the need for systemic antibiotic therapy. The active substance of Ambazon has a bacteriostatic effect when is kept in the mouth until it resorbs and is effective against Streptococcus haemolyticus , Streptococcus pneumoniae , Streptococcus viridans , and also has antifungal effects against Candida albicans yeast fungus, which is a saprophyte, but exhibits pathogenic properties in decreased body’s immune defence and dysbiosis. The use of topical antimicrobial therapy helps reduce inflammation and speed up the recovery of patients without prescription of systemic antibiotics, and also ensures the preservation of microbiome, reducing the probability of emergence of antibiotic resistant strains to the minimum.","PeriodicalId":36137,"journal":{"name":"Meditsinskiy Sovet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135978389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
I. N. Zakharova, I. V. Berezhnaya, V. V. Pupykina, A. D. Gostyukhina, N. F. Dubovets
Paracetamol (acetaminophen) and ibuprofen are commonly used to relieve fever and pain in children. Their effects are similar, but differ in strength and mechanisms of action on the body. Acetaminophen, a para-aminophenol derivative, has antipyretic and analgesic properties. Despite the fact that paracetamol has been officially used as a drug for more than 75 years, its mechanism of biological action has not been sufficiently studied. In paediatric practice, paracetamol is more often used as an antipyretic, but in recent years, with the development of technology and emergence of new dosage forms on the market, it came into common use as an analgesic in many diseases, including oncological, rheumatological, etc. Ibuprofen is the most commonly used non-steroidal anti-inflammatory drug with pronounced analgesic and antipyretic properties. Ibuprofen, a non-selective inhibitor of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2), affects the hypothalamic thermoregulatory center via inhibition of prostaglandin synthesis. In the paediatric population, the most common indications for the use of ibuprofen are fever, sore throat, ear pain, headache and toothache, post-traumatic and musculoskeletal pain, and inflammatory joint diseases. Paracetamol and ibuprofen are safe for use in paediatric practice, if dosing rules are observed, and are approved for use by the World Health Organization, FDA and other expert organizations. In addition, the emergence of new presentation forms of these drugs is most important in paediatrics.
{"title":"Paracetamol and ibuprofen in the treatment of pain and fever in children: modern views on the choice of a drug","authors":"I. N. Zakharova, I. V. Berezhnaya, V. V. Pupykina, A. D. Gostyukhina, N. F. Dubovets","doi":"10.21518/ms2023-367","DOIUrl":"https://doi.org/10.21518/ms2023-367","url":null,"abstract":"Paracetamol (acetaminophen) and ibuprofen are commonly used to relieve fever and pain in children. Their effects are similar, but differ in strength and mechanisms of action on the body. Acetaminophen, a para-aminophenol derivative, has antipyretic and analgesic properties. Despite the fact that paracetamol has been officially used as a drug for more than 75 years, its mechanism of biological action has not been sufficiently studied. In paediatric practice, paracetamol is more often used as an antipyretic, but in recent years, with the development of technology and emergence of new dosage forms on the market, it came into common use as an analgesic in many diseases, including oncological, rheumatological, etc. Ibuprofen is the most commonly used non-steroidal anti-inflammatory drug with pronounced analgesic and antipyretic properties. Ibuprofen, a non-selective inhibitor of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2), affects the hypothalamic thermoregulatory center via inhibition of prostaglandin synthesis. In the paediatric population, the most common indications for the use of ibuprofen are fever, sore throat, ear pain, headache and toothache, post-traumatic and musculoskeletal pain, and inflammatory joint diseases. Paracetamol and ibuprofen are safe for use in paediatric practice, if dosing rules are observed, and are approved for use by the World Health Organization, FDA and other expert organizations. In addition, the emergence of new presentation forms of these drugs is most important in paediatrics.","PeriodicalId":36137,"journal":{"name":"Meditsinskiy Sovet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135978388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
V. V. Platonov, T. A. Dubinina, E. M. Patrakeeva, A. A. Taraikovich
Introduction. Type 1 diabetes (T1D) is a chronic autoimmune disease requiring constant insulin therapy under regular continuous monitoring of glycemic parameters. The use of domestic insulin bioanalogues in CSII therapy is currently not sufficiently covered in the literature. Aim. To evaluate glycemic control parameters in children with T1D treated with the domestic fast-acting insulin aspart biosimilar by CSII. Materials and methods. Retrospective study was carried out on the basis of K.A. Raukhfus center St. Petersburg State Medical and Biomedical Center VMT. Fifty-five children with T1D aged 6 to 17 years (mean age 12 ± 4) were examined, including 29 boys (52.7%, mean age 11 ± 3 years) and 26 girls (47.3%, mean age 13 ± 4 years). Insulin therapy was carried out by systems of CSII Glycemic parameters were monitored by continuous and flash glycemic monitoring systems. The center visits frequency was once a month. Results . During dynamic follow-up after 3 and 6 months, children showed statistically significant (p < 0.05) improvement in glycemic control parameters–decrease in HbA1c level from 8.0 ± 1.8% to 7, 1 ± 1.2% and 6.8 ± 0.6%, increase in TIR from 60.4 ± 20.6% to 71.5 ± 13.0% and 75.9 ± 9.4%, decrease in TAR from 31.1 ± 22.1% to 23.0 ± 12.8% and 20.3 ± 9.3%, decrease in TBR from 9.1 ± 8.2% to 5.8 ± 4.3% and 4.1 ± 1.8%, and decrease in CV from 40.0 ± 9.1% to 33.7 ± 6.7% and 32.5 ± 5.6%. Discussion. The use of domestic biosimilar insulin aspart in insulin pumps iis associated with significant improvement in glycemic control in children and adolescents with T1D. Dynamic observation together with therapeutic education contribute to the maintenance of the achieved parameters at a high level. Conclusions. Therapy with the domestic fast-acting insulin aspart biosimilar by CSII allows achieving target glycemic control in children with T1D.
{"title":"Glycemic control parameters in children with type 1 diabetes treated with fast-acting insulin aspart domestic biosimilar by continuous subcutaneous infusion","authors":"V. V. Platonov, T. A. Dubinina, E. M. Patrakeeva, A. A. Taraikovich","doi":"10.21518/ms2023-329","DOIUrl":"https://doi.org/10.21518/ms2023-329","url":null,"abstract":"Introduction. Type 1 diabetes (T1D) is a chronic autoimmune disease requiring constant insulin therapy under regular continuous monitoring of glycemic parameters. The use of domestic insulin bioanalogues in CSII therapy is currently not sufficiently covered in the literature. Aim. To evaluate glycemic control parameters in children with T1D treated with the domestic fast-acting insulin aspart biosimilar by CSII. Materials and methods. Retrospective study was carried out on the basis of K.A. Raukhfus center St. Petersburg State Medical and Biomedical Center VMT. Fifty-five children with T1D aged 6 to 17 years (mean age 12 ± 4) were examined, including 29 boys (52.7%, mean age 11 ± 3 years) and 26 girls (47.3%, mean age 13 ± 4 years). Insulin therapy was carried out by systems of CSII Glycemic parameters were monitored by continuous and flash glycemic monitoring systems. The center visits frequency was once a month. Results . During dynamic follow-up after 3 and 6 months, children showed statistically significant (p < 0.05) improvement in glycemic control parameters–decrease in HbA1c level from 8.0 ± 1.8% to 7, 1 ± 1.2% and 6.8 ± 0.6%, increase in TIR from 60.4 ± 20.6% to 71.5 ± 13.0% and 75.9 ± 9.4%, decrease in TAR from 31.1 ± 22.1% to 23.0 ± 12.8% and 20.3 ± 9.3%, decrease in TBR from 9.1 ± 8.2% to 5.8 ± 4.3% and 4.1 ± 1.8%, and decrease in CV from 40.0 ± 9.1% to 33.7 ± 6.7% and 32.5 ± 5.6%. Discussion. The use of domestic biosimilar insulin aspart in insulin pumps iis associated with significant improvement in glycemic control in children and adolescents with T1D. Dynamic observation together with therapeutic education contribute to the maintenance of the achieved parameters at a high level. Conclusions. Therapy with the domestic fast-acting insulin aspart biosimilar by CSII allows achieving target glycemic control in children with T1D.","PeriodicalId":36137,"journal":{"name":"Meditsinskiy Sovet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135978394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：